Regina Miracle Fiscal 2023 Interim Results Revenue Reaches HK$4.61 Billion; Hitting a Record High for the Period, Net Profit Rose 23.1% to HK$313 Million

HONG KONG, Nov 29, 2022 – (ACN Newswire via SEAPRWire.com) – Regina Miracle International (Holdings) Limited (“Regina Miracle” or the “Company”, together with its subsidiaries, collectively the “Group”) (HKEX: 2199), a leading global intimate wear company boasting an innovative design manufacturer (“IDM”) business model, has announced its interim results for the six months ended 30 […]

Tianda Pharma Announces 2022/23 Interim Results

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharma” or “the Group”; stock code: 0455.HK) today announced its interim results for the six months ended 30 September 2022 (“the Period”). During the Period, the Group adopted proactive marketing strategy and improved its results notably. Its revenue increased by […]

CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy

SHENZHEN, CHINA, Aug 26, 2022 – (ACN Newswire via SEAPRWire.com) – China Medical System Holdings Limited (“CMS”, 867.HK) released its 2022 interim report on August 22. In the first half of 2022, CMS delivered an outstanding interim results — it achieved stable performance growth in several business segments, and solid progress in clinical development and […]

Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully

HONG KONG, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. MicuRx Pharmaceuticals issued 130,000,000 shares this time, accounting for 19.84% of the total share capital after the issuance. The total amount […]